There’s a growing, largely invisible pressure building inside organisations. One that’s quietly chipping away at productivity, decision-making and long-term cost control. It’s not market volatility or talent shortages. It’s dysregulated glucose.
For those of us operating at C-suite, HR and risk level, this isn’t a lifestyle conversation anymore. It’s a business-critical issue. Left unaddressed, it becomes a hidden liability embedded across the workforce which is impacting cognitive performance, increasing healthcare costs and weakening organisational resilience.
The scale of the issue we’re not talking about
In the UK today, roughly one in five adults is living with diabetes or prediabetes. That’s over 12 million people dealing with abnormal glucose regulation and many of whom are active in the workforce.
What’s more concerning is how much of this remains under the radar. Alongside the 4.6 million diagnosed cases, there are millions more with prediabetes or undiagnosed type 2 diabetes. In practical terms, that means a significant proportion of your employees; managers, high performers, even those in safety-critical roles; may already be operating with impaired glucose control without knowing it.
From a business perspective, this isn’t marginal. It’s systemic.
The impact on performance is real—and measurable
Glucose isn’t just a health metric; it’s a performance driver.
Research consistently shows that impaired glucose regulation affects memory, learning, reaction times and overall cognitive flexibility. These aren’t abstract clinical findings as they translate directly into how effectively people think, decide and execute at work.
What’s particularly important is that these effects begin early. Even before a formal diagnosis of type 2 diabetes, individuals with insulin resistance or early-stage dysregulation can experience subtle but meaningful declines in focus and mental agility.
So, you end up with capable people delivering below their potential and it’s not because of skill gaps, but because of underlying physiological factors that haven’t been identified or managed.
The cost to business goes far beyond absenteeism
When we talk about health-related productivity loss, the default assumption is absenteeism. But the bigger issue here is presenteeism! People being at work but not operating at full capacity.
In some studies, individuals with poorly managed glucose levels showed productivity losses of over 25%. When you scale that across a workforce, the financial implications become significant often running into thousands per employee annually, and millions at organisational level.
And that’s before factoring in longer-term costs: increased healthcare claims, higher insurance premiums, and the operational risks associated with impaired decision-making in critical roles.
This is the kind of slow-burn cost that rarely shows up clearly on a balance sheet but steadily erodes performance and margin over time.
Why regular glucose tracking changes the equation
The shift from reactive healthcare to proactive management is where the opportunity lies.
Regular glucose tracking, in particularly through continuous monitoring, offers real-time visibility into how individuals are actually functioning day-to-day. It moves us beyond snapshot diagnostics to a more dynamic understanding of health and performance.
Employees using continuous monitoring often report better focus, fewer energy crashes and improved ability to manage their workload. Importantly, it also allows for early identification of risk. Often before traditional tests would flag an issue.
From a leadership standpoint, that’s a fundamental shift. Instead of dealing with the consequences of chronic conditions, you’re enabling earlier intervention, better self-management and more consistent performance across your teams.
What this means for leadership
For those shaping organisational strategy, this isn’t about adding another wellness initiative. It’s about recognising glucose regulation as a core factor in workforce performance and risk management.
If one in five adults is already affected and many more are on the spectrum, then every sizeable organisation is carrying this exposure whether it’s acknowledged or not.
Integrating glucose awareness and monitoring into occupational health strategies, benefits design and leadership wellbeing programmes isn’t just progressive—it’s pragmatic.
Done properly, it allows organisations to:
- Identify health risks earlier
- Support sustained cognitive performance
- Reduce long-term healthcare costs
- Strengthen overall workforce resilience
In a landscape defined by tight margins, ageing populations and rising chronic disease, the organisations that take this seriously will have a clear advantage.
The rest will continue absorbing the cost of a problem they can’t see but are already paying for.